OWP Pharmaceuticals Announces IND Approval and Patent Application for the First-Ever Liquid Oral Suspension Formulation of Topiramate for the Treatment of Epilepsy and Migraine
November 20, 2019 08:00 ET
|
OWP Pharmaceuticals
NAPERVILLE, Ill., Nov. 20, 2019 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
Renovation of Children's Hospital Rehab Unit Helps Children Walk with "ZeroG" Technology
October 25, 2019 09:26 ET
|
Children's Hospital of The King's Daughters
Norfolk, Va., Oct. 25, 2019 (GLOBE NEWSWIRE) -- A smile slowly spread across the face of 5-year-old Lucas Guinn as he felt a harness gently lift him aloft to walk across the room. Another...
Our Lady of the Lake Children’s Hospital Opens Doors Tomorrow, Oct. 5
October 04, 2019 15:00 ET
|
Franciscan Missionaries of Our Lady Health System
Baton Rouge, LA, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Our Lady of the Lake Children’s Hospital will open its doors tomorrow at 6 a.m., beginning a new chapter in the healthcare ministry’s history...
Rapid Influenza Diagnostic Tests Market to cross $689 million by 2025: Global Market Insights, Inc.
September 10, 2019 07:30 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Sept. 10, 2019 (GLOBE NEWSWIRE) -- U.S. rapid influenza diagnostic tests market was valued at USD 130.5 million in 2018 and is estimated to witness substantial amount of...
Bellicum Pharmaceuticals to Participate in Three Healthcare Investor Conferences during September
August 28, 2019 16:05 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood...
Bellicum Pharmaceuticals Announces Aggregate Gross Proceeds of $69.6 Million from $139.6 Million Public Offering and Private Placement
August 21, 2019 16:05 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood...
Bellicum Pharmaceuticals Announces Proposed $53.0 Million Public Offering of Preferred Stock and Warrants with Concurrent Private Placement
August 15, 2019 17:37 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood...
Vaccines Market value to hit $72.5 billion by 2025: Global Market Insights, Inc.
August 15, 2019 02:30 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Global Market Insights, Inc., announces a research report on ‘Vaccines Market Trends and Forecast 2019-2025’. The report covers an extensive...
Bellicum Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Operational Update
August 05, 2019 16:15 ET
|
Bellicum Pharmaceuticals, Inc.
Interim safety and activity data for BPX-601 presented at American Society of Clinical Oncology (ASCO) Annual Meeting Rivo-celTM achieved primary endpoint in BP-004 European registrational trial ...
Novan SB206 Phase 3 Molluscum Pivotal Program Update
July 11, 2019 08:15 ET
|
Novan, Inc.
More than 50 percent of total expected patients now enrolledVirtually all of the clinical sites now active Discipline and execution focus remain of equal importance to recruitment activity ...